NEKTAR THERAPEUTICS Annual Costs and Expenses in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Nektar Therapeutics quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
  • Nektar Therapeutics Costs and Expenses for the quarter ending June 30, 2024 was $73.3M, a 3.05% increase year-over-year.
  • Nektar Therapeutics Costs and Expenses for the twelve months ending June 30, 2024 was $257M, a 32.4% decline year-over-year.
  • Nektar Therapeutics annual Costs and Expenses for 2023 was $354M, a 24.4% decline from 2022.
  • Nektar Therapeutics annual Costs and Expenses for 2022 was $468M, a 14.6% decline from 2021.
  • Nektar Therapeutics annual Costs and Expenses for 2021 was $548M, a 5.19% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $354M -$114M -24.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $468M -$79.8M -14.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $548M -$30M -5.19% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $578M +$23.4M +4.21% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $555M +$49.3M +9.75% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $505M +$138M +37.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $367M +$89.1M +32% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $278M +$18.1M +6.97% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $260M +$43M +19.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $217M -$51.9M -19.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $269M +$46.7M +21% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
2012 $222M +$27M +13.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 $195M +$8.12M +4.34% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 $187M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.